Jessica Garbern, MD, PhD
Cardiologist, Department of Cardiology
Instructor of Pediatrics, Harvard Medical School
Image
Jessica Garbern, MD, PhD
Cardiologist, Department of Cardiology
Instructor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
University of Michigan
Ann Arbor
MI
Graduate School
University of Washington
Seattle
WA
Medical School
University of Washington
Seattle
WA
Residency
Boston Combined Residency Program (BCRP)
Boston
MA
Residency
Boston Combined Residency Program (BCRP)
Boston
MA
Fellowship
Boston Children's Hospital
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Cardiology)
Publications
P53 Activation Promotes Maturational Characteristics of Pluripotent Stem Cell-Derived Cardiomyocytes in 3-Dimensional Suspension Culture Via FOXO-FOXM1 Regulation. View Abstract
Discovery adductomics provides a comprehensive portrait of tissue-, age- and sex-specific DNA modifications in rodents and humans. View Abstract
Tissue-embedded stretchable nanoelectronics reveal endothelial cell-mediated electrical maturation of human 3D cardiac microtissues. View Abstract
Senescence mechanisms and targets in the heart. View Abstract
Heart regeneration: 20 years of progress and renewed optimism. View Abstract
Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes. View Abstract
Sustained Activation of AMPK Enhances Differentiation of Human iPSC-Derived Cardiomyocytes via Sirtuin Activation. View Abstract
Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. View Abstract
Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. View Abstract
Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11. View Abstract
Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence. View Abstract
Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities. View Abstract
Analysis of Cre-mediated genetic deletion of Gdf11 in cardiomyocytes of young mice. View Abstract
Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis. View Abstract
Engineering of mature human induced pluripotent stem cell-derived cardiomyocytes using substrates with multiscale topography View Abstract
Into the hearts of babes: Stem cell therapy for pediatric heart failure. View Abstract
Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? View Abstract
Cardiac stem cell therapy and the promise of heart regeneration. View Abstract
Model systems for cardiovascular regenerative biology. View Abstract
Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. View Abstract
Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. View Abstract
Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. View Abstract
Locally enhanced angiogenesis promotes transplanted cell survival. View Abstract
Locations